The two-day virtual event will feature radiopharmaceutical companies both in the therapeutic and contract development and manufacturing space. In the next three to five years, we anticipate the therapeutics class to emerge from a niche modality to one of the centerpieces of cancer treatment paradigm. The conference will feature two keynote speakers along with management fireside chats and company presentations hosted by the William Blair Research team, discussing various aspects of the radiopharmaceuticals industry.